Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Fox, Caroline S, Matsushita, Kunihiro, Woodward, Mark, Bilo, Henk JG, Chalmers, John, Heerspink, Hiddo J Lambers, Lee, Brian J, Perkins, Robert M +9 more·2012·The Lancet

Cited by (1,001)

Items 401–500 of 1,001

  1. The Sympathetic Nervous System in Chronic Kidney Disease
    Sebastian Ewen, Christian Ukena, Dominik Linz, Roland Erich Schmieder, Michael Böhm, Felix Mahfoud · 2013 · Current Hypertension Reports
  2. Mortality landscape in the Global Burden of Diseases, Injuries and Risk Factors Study
    Boris T. Bikbov, Norberto Perico, Giuseppe Remuzzi · 2013 · European Journal of Internal Medicine
  3. Vitamin D analogues to target residual proteinuria: potential impact on cardiorenal outcomes
    Jelmer K. Humalda, David J.A. Goldsmith, Ravi Thadhani, Martin H. de Borst · 2015 · Nephrology Dialysis Transplantation
  4. Comparing SF-36® scores versus biomarkers to predict mortality in primary cardiac prevention patients
    Rony N. Lahoud, Vasutakarn Chongthammakun, Yuping Wu, Nael Hawwa, Danielle M. Brennan, Leslie Cho · 2017 · European Journal of Internal Medicine
  5. Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease
    Gerasimos S Filippatos, Stefan D. Anker, Bertram Pitt, Darren K. McGuire, Peter R Rossing, Luis Miguel Ruilope, Javed Butler, Ewa Anita Jankowska, Erin D. Michos, Dimitrios T. Farmakis et al. · 2022 · European Heart Journal - Cardiovascular Pharmacotherapy
  6. Empagliflozin treatment of cardiotoxicity: A comprehensive review of clinical, immunobiological, neuroimmune, and therapeutic implications
    Zahra Vaziri, Kiarash Saleki, Cena Aram, Parsa Alijanizadeh, Ramtin Pourahmad, Abbas Azadmehr, Naghmeh Ziaei · 2023 · Biomedicine & Pharmacotherapy
  7. Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes
    Colin J. Gimblet, Nicholas T. Kruse, Katharine M. Geasland, Jeni Michelson, Mingyao Sun, Safur Rehman Mandukhail, Linder Hagstrom Wendt, Patrick Ten Eyck, Gary L. Pierce, Diana I. Jalal · 2023 · Clinical Journal of the American Society of Nephrology
  8. Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure
    Anuradha Lala, Steven G. Coca, Jason Feinman, CARINE E. HAMO, Mona Fiuzat, William T. Abraham, Christopher M. O’Connor, JoAnn Lindenfeld, James L. Januzzi, Isabella Cavagna et al. · 2025 · Journal of the American College of Cardiology
  9. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice
    Yuta Takagaki, Sen Shi, Makoto Katoh, Munehiro Kitada, Keizo Kanasaki, Daisuke Koya · 2019 · Scientific Reports
  10. The association between distal symmetric polyneuropathy in diabetes with all-cause mortality – a meta-analysis
    Orsolya Erzsébet Vági, Márk M. Svébis, Beatrix Annamária Domján, Anna Erzsébet Körei, Solomon Hailemariam Tesfaye, Viktor József Horváth, Péter Kempler, Ádám Gyula Tabák · 2023 · Frontiers in Endocrinology
  11. Systemic Inflammation Is Associated With Coronary Artery Calcification and All-Cause Mortality in Chronic Kidney Disease
    In‐Chang Hwang, Hyo Eun Park, Hack‐Lyoung Kim, Hyue Mee Kim, Jun‐Bean Park, Yeonyee Elizabeth Yoon, Seung‐Pyo Lee, Hyung‐Kwan Kim, Goo‐Yeong Cho, Daewon Sohn et al. · 2016 · Circulation Journal
  12. High Triglycerides Predicts Arteriogenic Erectile Dysfunction and Major Adverse Cardiovascular Events in Subjects with Sexual Dysfunction
    Giovanni Corona, Sarah Cipriani, Giulia Rastrelli, Alessandra Sforza, Edoardo Mannucci, Mario Maggi · 2016 · The Journal of Sexual Medicine
  13. NMDA receptors participate in the progression of diabetic kidney disease by decreasing Cdc42‐GTP activation in podocytes
    Jia Yun Shen, Rending Wang, Zhechi He, Hongfeng Huang, Xuelin He, Jingyi Zhou, Ying-Gang Yan, Shuijuan Shen, Xue Shao, Xiujin Shen et al. · 2016 · The Journal of Pathology
  14. Estimated Glomerular Filtration Rate and Albuminuria Are Associated with Biomarkers of Cardiac Injury in a Population-Based Cohort Study: The Maastricht Study
    Remy J.H. Martens, Dorien M Kimenai, Jeroen Peter Kooman, Coen D.A. Stehouwer, Frans E. S. Tan, Otto Bekers, Pieter C. Dagnelie, Carla Kallen, Abraham A. Kroon, Karel M.L. Leunissen et al. · 2017 · Clinical Chemistry
  15. Circulating TNF receptors 1 and 2 predict progression of diabetic kidney disease: A meta‐analysis
    Xiaoqi Ye, Ting Luo, Kanran Wang, Yue Wang, Shumin Yang, Qifu Li, Jinbo Hu · 2019 · Diabetes/Metabolism Research and Reviews
  16. Insulin resistance underlies the elevated cardiovascular risk associated with kidney disease and glomerular hyperfiltration
    María M. Adeva‐Andany, Carlos Fernández‐Fernández, Natalia Carneiro-Freire, Elvira Castro-Quintela, Ana María Pedre‐Piñeiro, Mónica Seco-Filgueira · 2020 · Reviews in Cardiovascular Medicine
  17. Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions
    María Antonietta Barbieri, Michelangelo Rottura, Giuseppe Cicala, Rossella Mandraffino, Sebastiano Marino, Natasha Irrera, Carmen Mannucci, Domenico Santoro, Francesco Squadrito, Vincenzo Arcoraci · 2020 · Journal of Clinical Medicine
  18. Diabetes that impacts on routine activities predicts slower recovery after total knee arthroplasty: an observational study
    Nurudeen Amusat, Lauren A Beaupré, Gian Singh Jhangri, Sheri L. Pohar, Scot H. Simpson, Sharon Warren, C Allyson Jones · 2014 · Journal of physiotherapy
  19. Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes
    Gregory A. Nichols, Anouk Déruaz‐Luyet, Kimberly Goodnow Brodovicz, Teresa M. Kimes, A. Gabriela Rosales, Sibylle Jenny Hauske · 2020 · BMC Nephrology
  20. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update
    Zoi Kleinaki, Stella Kapnisi, Sofia‐Andriani Theodorelou‐Charitou, Ilias P. Nikas, Stavroula Α. Paschou · 2020 · HORMONES
  21. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024
    Sagen Zac‐Varghese, Patrick Barry Mark, Steve C Bain, Debasish Banerjee, Tahseen Ahmad Chowdhury, Indranil Dasgupta, Parijat De, Damian G. Fogarty, Andrew Frankel, Gabrielle Goldet et al. · 2024 · BMC Nephrology
  22. Albuminuria as a Diagnostic Criterion and a Therapeutic Target in Heart Failure and Other Cardiovascular Disease
    Biykem Bozkurt, Patrick Rossignol, Joseph A. Vassalotti · 2025 · European Journal of Heart Failure
  23. Prehypertension and Chronic Kidney Disease in Chinese Population: Four-Year Follow-Up Study
    Hao Xue, JianLi Wang, Jinhong Hou, Junjuan Li, Jingsheng Gao, Shuohua Chen, Hang Zhu, Shouling Wu · 2015 · PLoS ONE
  24. Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial
    Ofri Mosenzon, Stephen Charles Bain, Hiddo J.L. Heerspink, Thomas Idorn, Johannes F.E. Mann, Frederik Persson, Richard E. Pratley, Søren Rasmussen, Peter R Rossing, Bernt Johan von Scholten et al. · 2020 · Diabetes Obesity and Metabolism
  25. Potassium reduction in food by preparation technique for the dietetic management of patients with chronic kidney disease: a review
    Raíssa Aparecida Borges Batista, Camila Cremonezi Japúr, Isaías Valente Prestes, J. Fortunato Silva, M. Cavanha, Geórgia das Graças Pena · 2021 · Journal of Human Nutrition and Dietetics
  26. Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities
    Shuchi Anand, Dimple Kondal, Maria E. Montez‐Rath, Yuanchao Zheng, Roopa Shivashankar, Kalpana Singh, Priti Gupta, Ruby Gupta, Vamadevan S. Ajay, Viswanathan Mohan et al. · 2017 · PLoS ONE
  27. Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease : A mixed‐methods study
    Pamela A Lopez‐Vargas, Allison Tong, Martin Howell, Richard K. S. Phoon, Steven James Chadban, Yvonne Shen, Jonathan C. Craig · 2016 · Nephrology
  28. Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial
    João Pedro Ferreira, C R Mehta, Abhinav Sharma, Steven E. Nissen, Patrick Rossignol, Faiez M. Zannad · 2020 · BMC Medicine
  29. Smoking habit as a risk amplifier in chronic kidney disease patients
    Michele Provenzano, Raffaele Serra, Ashour Michael, Davide Bolignano, Giuseppe Coppolino, Nicola Ielapi, Giuseppe Filiberto Serraino, Pasquale Mastroroberto, Francesco Locatelli, Luca De Nicola et al. · 2021 · Scientific Reports
  30. Framing Cause-Effect Relationship of Acute Coronary Syndrome in Patients with Chronic Kidney Disease
    Mădălina Ioana Moisi, SIMONA GABRIELA BUNGAU, Cosmin Mihai Vesa, Camelia Cristina Diaconu, Tapan Behl, Manuela Stoicescu, Mirela Mărioara Toma, Cristiana Bustea, Cristian Nicolae Sava, Mircea Ioachim Popescu · 2021 · Diagnostics
  31. Association between bone mineral metabolism and vascular calcification in end-stage renal disease
    Louise Aaltonen, Niina S. Koivuviita, Marko Seppänen, Heikki Kröger, Xiaoyu F. Tong, Eliisa Löyttyniemi, Kaj Peter Metsarinne · 2022 · BMC Nephrology
  32. Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
    Hugh Gallagher, Jennifer Dumbleton, Tom Maishman, Amy L. Whitehead, Michael V Moore, Ahmet Fuat, David Andrew Fitzmaurice, Robert A. Henderson, Joanne L. Lord, Kathryn E Griffith et al. · 2022 · Trials
  33. Emerging drugs for the treatment of diabetic nephropathy
    Yoon Kook Kim, Xinyuan Ning, Kashif M. Munir, Stephen N. Davis · 2022 · Expert Opinion on Emerging Drugs
  34. Burden of end-stage renal disease of undetermined etiology in Africa
    Temesgen Fiseha, Nicholas John Osborne · 2023 · Renal Replacement Therapy
  35. Is Fluid Overload More Important than Diabetes in Renal Progression in Late Chronic Kidney Disease?
    Yi‐Chun Tsai, Jer-Chia Tsai, Yi‐Wen Chiu, Hung‐Tien Kuo, Szu‐Chia Chen, Shang‐Jyh Hwang, Tzu-Hui Chen, Mei‐Chuan Kuo, Hung‐Chun Chen · 2013 · PLoS ONE
  36. Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes
    Francesca Chiara Viazzi, Pamela Angela Piscitelli, Carlo Bruno Giorda, Antonio Ceriello, Stefano Genovese, Giuseppina Tiziana Russo, Paola Fioretto, Pietro Guida, Salvatore De Cosmo, Roberto Pontremoli · 2016 · Journal of Diabetes and its Complications
  37. Effectiveness of an oral diabetes-specific supplement on nutritional status, metabolic control, quality or life, and functional status in elderly patients. A multicentre study
    Pilar Matía-Martín, Francisco Robles Agudo, José Antonio Medina, Alejandro Sanz París, Francisco José Tarazona‐Santabalbina, J. R. Doménech Pascual, Luis Lopez‐Penabad, Rebeca Sanz Barriuso · 2018 · Clinical Nutrition
  38. Canakinumab: Promises and Future in Cardiometabolic Diseases and Malignancy
    Aneesh Dhorepatil, Somedeb Ball, Raktim Kumar Ghosh, Meera Devi Kondapaneni, Carl J. Lavie · 2018 · The American Journal of Medicine
  39. Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
    Emmanuelle Vidal‐Petiot, Nicola Greenlaw, Paul R. Kalra, Xavier García–Moll, Jean‐Claude Tardif, Ian Ford, José Zamorano, Roberto Ferrari, Michał Tendera, Kim Michael Fox et al. · 2019 · Journal of Clinical Medicine
  40. Emerging Targets for Cardiovascular Disease Prevention in Diabetes
    Nathan O. Stitziel, Jenny E. Kanter, Karin Bornfeldt · 2020 · Trends in Molecular Medicine
  41. Pathogenesis of diabesity‐induced kidney disease: role of kidney nutrient sensing
    L. Hinden, Aviram Kogot-Levin, J. Tam, G. Leibowitz · 2021 · The FEBS Journal
  42. Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease
    Xian Chen, Wenni Dai, Hao Li, Zhe Yan, Zhiwen Liu, Liyu He · 2022 · Drug Delivery
  43. Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes
    Jee Hee Yoo, Ji Yoon Kim, Jae Hyeon Kim · 2023 · Diabetes Technology & Therapeutics
  44. Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice
    Yong‐ho Lee, Chan Joo Lee, Hye Sun Lee, Eun Yeong Choe, Byung‐Wan Lee, Chul Woo Ahn, B.-S. Cha, H.C. Lee, Beverley Balkau, Eun Seok Kang · 2015 · Diabetes & Metabolism
  45. Predictive value of dynamic renal resistive index (drin) for renal outcome in type 2 diabetes and essential hypertension: a prospective study
    Rosa María Bruno, Antonio Salvati, M. Barzacchi, Katia Raimo, Stefano Taddei, Lorenzo Ghiadoni, Anna Solini · 2015 · Cardiovascular Diabetology
  46. Perceptions of Prognostic Risks in Chronic Kidney Disease: A National Survey
    Helen Chiu, Navdeep Tangri, Ognjenka Djurdjev, Brendan J. Barrett, Brenda R. Hemmelgarn, François Madore, Claudio Rigatto, Norman Muirhead, Manish M. Sood, Catherine M. Clase et al. · 2015 · Canadian Journal of Kidney Health and Disease
  47. Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
    Magdalena Rysz-Górzyńska, Maciej Banach · 2016 · Archives of Medical Science
  48. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia
    Temesgen Fiseha, Zemenu Tamir · 2020 · BMC Nephrology
  49. Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement
    Kalyani, Rita R, Allende-Vigo, Myriam Z, Antinori-Lent, Kellie J, Close, Kelly L, Das, Sandeep R, Deroze, Phyllisa, Edelman, Steven V, El Sayed, Nuha A, Kerr, David, Neumiller, Joshua J et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
  50. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study
    Ionut Bebu, Barbara H. Braffett, Ian H. de Boer, Lloyd Paul Aiello, John P. Bantle, Gayle M. Lorenzi, William H. Herman, Rose Gubitosi‐Klug, Bruce A. Perkins, John M. Lachin et al. · 2022 · Diabetes Care
  51. Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
    M. Ali, Sanober Parveen, Vanessa R. Williams, Robert F. Dons, G. Uwaifo · 2024 · Journal of Clinical & Translational Endocrinology
  52. The effect of HIV infection on glycaemia and renal function in type 2 diabetic patients
    Siyabonga P. Khoza, Nigel John Crowther, Sindeep Bhana · 2018 · PLoS ONE
  53. Association between visceral adiposity index and chronic kidney disease: Evidence from the China Health and Retirement Longitudinal Study
    Xiaowei Zheng, Longyang Han, Suwen Shen, Wenyan Wu · 2022 · Nutrition Metabolism and Cardiovascular Diseases
  54. The Role of Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
    Christodoula Kourtidou, Κωνσταντίνος Τζιόμαλος · 2023 · International Journal of Molecular Sciences
  55. Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study
    Dea Haagensen Kofod, Nicholas Carlson, Ellen Linnea Freese Ballegaard, Thomas Almdal, Christian Tobias Torp-Pedersen, Gunnar Gislason, Jesper Hastrup Svendsen, Bo Feldt‐Rasmussen, Mads Hornum · 2023 · Cardiovascular Diabetology
  56. Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study
    LOD-DIABETES Group, Manuel Ángel Gómez-Marcos, Jose Ignacio Recio-Rodriguez, Leticia Gómez‐Sánchez, Cristina Agudo‐Conde, Emiliano Rodríguez‐Sánchez, José Ángel Maderuelo-Fernández, Marta Gómez‐Sánchez, Luis García‐Ortiz · 2015 · Cardiovascular Diabetology
  57. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression
    Elise Schutte, Ron T. Gansevoort, Jacqueline Benner, Helen L. Lutgers, Hiddo J.L. Heerspink · 2015 · Nephrology Dialysis Transplantation
  58. The relationship between three eGFR formulas and hospitalization for heart failure in 54 486 individuals with type 2 diabetes
    Mauro Tancredi, Annika Rosengren, Marita Olsson, Soffia Guðbjörnsdóttir, Ann‐Marie Svensson, Börje S. Haraldsson, Marcus Lind · 2016 · Diabetes/Metabolism Research and Reviews
  59. Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry
    Jay Shavadia, Danielle A. Southern, Matthew Thomas James, Robert C. Welsh, Kevin R. Bainey · 2017 · European Heart Journal - Quality of Care and Clinical Outcomes
  60. The relationship between estimated glomerular filtration rate trajectory and all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study
    Timothy M. E. Davis, Stephen A. Paul Chubb, Wendy Angela Davis · 2016 · European Journal of Endocrinology
  61. Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
    Dongqi Zhou, Ting Zhou, Shiyun Tang, Qing Li, Wen Li, Gaofeng Gan, Mingqiao Li, Chen Qiu · 2024 · Frontiers in Endocrinology
  62. Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism
    Ruo-Ying Li, Liang Guo · 2024 · International Journal of Molecular Sciences
  63. Population‐Based Study on the Coexistence of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Chronic Kidney Disease
    Rachel Sze Jen Goh, Jaycie Koh, Made Ayu Utami Intaran, Yip Han Chin, Gwyneth Kong, Bryan Chong, Jobelle Chia, Mark Y. Chan, Anurag Mehta, Mark Dhinesh Muthiah et al. · 2025 · Journal of the American Heart Association
  64. Annual deterioration of renal function in hypertensive patients with and without diabetes
    Jorge Junqueira Polónia, André Costa Azevedo, Miguel Monte, José Iranildo Barbosa Sales da Silva, Susana Bertoquini · 2017 · Vascular Health and Risk Management
  65. Cardiovascular protection with sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Does it apply to all patients?
    F. Giorgino, J. Vora, P. Fenici, A. Solini · 2020 · Diabetes, obesity and metabolism
  66. Separating the wheat from the chaff—COVID-19 in a German emergency department: a case-control study
    David Fistera, Dirk Pabst, Annalena Härtl, Benedikt M. Schaarschmidt, Lale Umutlu, Sebastian Dolff, Carola Holzner, Clemens Kill, Joachim Riße · 2020 · International Journal of Emergency Medicine
  67. The association between trajectories of risk factors and risk of cardiovascular disease or mortality among patients with diabetes or hypertension: A systematic review
    Yuan Wang, Eric Yuk Fai Wan, Ivy Lynn Mak, Margaret Kay Ho, Weng Yee Chin, Esther Yee Tak Yu, Cindy Lo Kuen Lam · 2022 · PLoS ONE
  68. The Lower Limit of Reference of Urinary Albumin/Creatinine Ratio and the Risk of Chronic Kidney Disease Progression in Patients With Type 2 Diabetes Mellitus
    Wei-Hua Tang, Wei‐Chin Hung, Chao-Ping Wang, Cheng‐Ching Wu, Chin‐Feng Hsuan, Teng‐Hung Yu, Chia‐Chang Hsu, Ya-Ai Cheng, Fu‐Mei Chung, Yau‐Jiunn Lee et al. · 2022 · Frontiers in Endocrinology
  69. Diet therapy along with nutrition education can improve renal function in people with stages 3–4 chronic kidney disease who do not have diabetes: a randomised controlled trial
    Maryam Hamidianshirazi, Maryam Shafiee, Maryam Ekramzadeh, Mahsa Torabi Jahromi, Farzad Nikaein · 2022 · British Journal Of Nutrition
  70. Apolipoprotein M in patients with chronic kidney disease
    Ida Maria Hjelm Sørensen, Marianne Bertelsen, Ellen Linnea Freese Ballegaard, Kristine Lindhard, Henrik Ullum, Bo Feldt‐Rasmussen, Lars B. Nielsen, Christina Christoffersen, Susanne Bro · 2018 · Atherosclerosis
  71. Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study
    Maria Fusaro, Mario Gennaro Cozzolino, Mario Plebani, Giorgio Iervasi, Markus Ketteler, Maurizio Alberto Gallieni, Andrea Aghi, Francesco Locatelli, John Cunningham, Syazrah Salam et al. · 2020 · Journal of Bone and Mineral Research
  72. A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis
    Karin Bornfeldt, Farah Kramer, Anna Batorsky, Jinkuk Choi, Kelly L. Hudkins, Peter Tontonoz, Charles E. Alpers, Jenny E. Kanter · 2017 · American Journal Of Pathology
  73. Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020
    Liaw, Julia, Harhay, Meera, Setoguchi, Soko, Gerhard, Tobias, Dave, Chintan V. · 2022 · Diabetes Care
  74. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes
    Cinzia Magagnotti, Gianpaolo Zerbini, Isabella Fermo, Rose Mary Carletti, Riccardo Bonfanti, Fabiana Vallone, Annapaola Andolfo · 2018 · Journal of Proteomics
  75. Undiagnosed and untreated chronic kidney disease and its impact on renal outcomes in the Japanese middle-aged general population
    Yukari Yamada, Tatsuyoshi Ikenoue, Yoshiyuki Saito, Shingo Fukuma · 2019 · Journal of Epidemiology & Community Health
  76. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus
    Honghong Ren, Lijun Zhao, Yutong Zou, Yiting Wang, Junlin Zhang, Yucheng Wu, Rui Zhang, Tingli Wang, Jiali Wang, Yitao Zhu et al. · 2021 · Renal Failure
  77. Concomitant diabetes with atrial fibrillation and anticoagulation management considerations
    Reinhold Hugo Kreutz, A. John Camm, Peter R Rossing · 2020 · European Heart Journal Supplements
  78. Altered Gray Matter Volume, Functional Connectivity, and Degree Centrality in Early-Onset Type 2 Diabetes Mellitus
    Yue Feng, Yifan Li, Xin Lin Tan, Yi Liang, Xiaomeng Ma, Yuna Chen, Wenjiao Lv, Jinjian Wu, Shangyu Kang, Mingrui Li et al. · 2021 · Frontiers in Neurology
  79. Association of chronic kidney disease (CKD) and failure to monitor renal function with adverse outcomes in people with diabetes: a primary care cohort study
    Andrew Peter McGovern, Benjamin Rusholme, Simon Jones, Jeremy N van Vlymen, Harshana Liyanage, Hugh Gallagher, Charles Tomson, Kamlesh K. Khunti, Kevin M. Harris, Simon de Lusignan · 2013 · BMC Nephrology
  80. Predictors for the development of microalbuminuria and interaction with renal function
    Christos Chatzikyrkou, Jan Menne, Joseph L. Izzo, Giancarlo C. Viberti, Ton J. Rabelink, Luis Miguel Ruilope, Christian Rump, Peter Rene Mertens, Hermann G. Haller · 2017 · Journal of Hypertension
  81. Screening chronic kidney disease through deep learning utilizing ultra-wide-field fundus images
    Xinyu Zhao, Xingwang Gu, Lihui Meng, Yongwei Chen, Qing Zhao, Shiyu Cheng, Wenfei Zhang, Tiantian Cheng, Chuting Wang, Zhengming Shi et al. · 2024 · npj Digital Medicine
  82. Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis
    Sankar Dass Navaneethan, Stefan D. Anker, Gerasimos S Filippatos, Bertram Pitt, Peter R Rossing, Luis Miguel Ruilope, Phyllis August, MEIKE DANIELA BRINKER, Andrea Z. Lage, Luke Roberts et al. · 2025 · Kidney International
  83. The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands
    Gerjan J Navis, Peter J. Blankestijn, Jeroen K. Deegens, Johan Willem de Fijter, Jaap J. Homan van der Heide, Ton J. Rabelink, Raymond Theodorus Krediet, Arjan J. Kwakernaak, Gozewijn Dirk Laverman, Karel M.L. Leunissen et al. · 2013 · Nephrology Dialysis Transplantation
  84. Decreased renal function and associated factors in cities, towns and rural areas of Tanzania: a community‐based population survey
    Robert N. Peck, Kathy J. Baisley, Bazil Baltazar Kavishe, Jackson Were, Janneth Maridadi Mghamba, Liam L Smeeth, Heiner Grosskurth, Saidi Kapiga · 2015 · Tropical Medicine & International Health
  85. eGFRs from Asian-modified CKD-EPI and Chinese-modified CKD-EPI equations were associated better with hypertensive target organ damage in the community-dwelling elderly Chinese: the Northern Shanghai Study
    Hongwei Ji, Han Zhang, Jing Xiong, Shikai Yu, Chen Chi, Bin Bai, Jue Li, Jacques Blacher, Yi Zhang, Yawei Xu · 2017 · Clinical Interventions in Aging
  86. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria
    Alex R. Chang, Holly Kramer, Guo Wei, Robert E. Boucher, Morgan Erika Grams, Dan R. Berlowitz, Udayan Y. Bhatt, Debbie L. Cohen, Paul E. Drawz, Henry A. Punzi et al. · 2020 · Clinical Journal of the American Society of Nephrology
  87. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study
    Xi Yao, Wenhua Lei, Nan Shi, Weiqiang Lin, Xiaoying Du, Ping Zhang, Jianghua Chen · 2020 · BMC Nephrology
  88. Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors at 5 Years
    Anna Marie Price, William Edward Moody, Victoria Stoll, Ravi Vijapurapu, Manvir Kaur Hayer, Luca Biasiolli, Chris J. Weston, Rachel Webster, Roman Wesołowski, Kirsty C. McGee et al. · 2021 · Hypertension
  89. Correlation between left ventricular diastolic dysfunction and dyslipidaemia in asymptomatic patients with new-onset type 2 diabetes mellitus
    K. M. Hassan Ayman, A. Abdallah Mahmoud, A. Abdel-Mageed Eman, Sayed Marwa, M. Soliman Mona, Tasnem Yehia · 2021 · The Egyptian Journal of Internal Medicine
  90. Multimorbidity prevalence and patterns and their associations with health literacy among chronic kidney disease patients
    Matheus S Gurgel do Amaral, Sijmen A. Reijneveld, Laura M G Meems, Josué Almansa, Gerjan J Navis, Andrea F. de Winter · 2022 · Journal of Nephrology
  91. Chronic Renal Failure and Cardiovascular Disease: A Comprehensive Appraisal
    Keren Skalsky, Arthur Shiyovich, Tali Steinmetz, Ran Kornowski · 2022 · Journal of Clinical Medicine
  92. KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD
    Amy K. Mottl, Susanne B. Nicholas · 2023 · American Journal of Kidney Diseases
  93. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care
    Alfredo Caturano, Raffaele Galiero, Maria Paola Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Davide Nilo, Giovanni Di Lorenzo, Celestino Sardu, Erica Vetrano, Marcellino Monda et al. · 2024 · Biomedicines
  94. Kidney Measures with Diabetes and Hypertension on Cardiovascular Disease: The Atherosclerosis Risk in Communities Study
    Nadine Alexander, Kunihiro Matsushita, Yingying Sang, Shoshana H. Ballew, Bakhtawar Khan Mahmoodi, Brad C. Astor, Josef Coresh · 2015 · American Journal of Nephrology
  95. Urinary Albumin-Creatinine Ratio, Estimated Glomerular Filtration Rate, and All-Cause Mortality Among US Adults With Obstructive Lung Function
    Earl S. Ford · 2014 · CHEST Journal
  96. Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria
    Simon DS Fraser, Paul J. Roderick, Natasha J. McIntyre, Scott Harris, Christopher William McIntyre, Richard Fluck, Maarten W. Taal · 2014 · PLoS ONE
  97. Plasma Molecular Signatures in Hypertensive Patients With Renin–Angiotensin System Suppression
    Montserrat Baldan Martin, Laura Mouriño-Álvarez, Laura Gonzalez‐Calero, Rafael Moreno‐Luna, Tamara Sastre-Oliva, Gema Ruiz‐Hurtado, J. Segura, Juan Antonio López, Jesús Vázquez, Fernando Vivanco et al. · 2016 · Hypertension
  98. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD
    David M. Charytan, Scott David Solomon, Peter T. Ivanovich, Giuseppe Remuzzi, Mark Emmanuel Cooper, Janet B. McGill, Hans‐Henrik Parving, Patrick S. Parfrey, Ajay K. Singh, Emmanuel A. Burdmann et al. · 2017 · American Journal of Kidney Diseases
  99. Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol
    Neda Zafari, Leonid P. Churilov, Richard J. MacIsaac, Niloufar Torkamani, Helen Baxter, Katerina Kiburg, Elif Ilhan Ekinci · 2019 · BMJ Open
  100. Linking Kidney and Cardiovascular Complications in Diabetes—Impact on Prognostication and Treatment: The 2019 Edwin Bierman Award Lecture
    Peter R Rossing, Frederik Persson, Marie Frimodt‐Møller, Tine W. Hansen · 2020 · Diabetes